韩国做爰无遮A片床戏,第一财经电视直播,女人18毛片水真多,老头猛吸女大学奶头A片,借种灭门案完整观看国语

Journal Of Medical And Biomedical Science
收藏雜志
  • 數據(ju)庫收錄SCIE
  • 年發(fa)文量3

Journal Of Medical And Biomedical Science

期(qi)刊(kan)中文名(ming):醫學與生(sheng)物醫學科(ke)學雜志(zhi)ISSN:2026-6294

該雜志(zhi)國(guo)際(ji)簡稱:J MED BIOMED SCI,是一本致(zhi)力于發(fa)布--研究新成果的(de)的(de)專業學(xue)術(shu)期刊。主要發(fa)表(biao)刊登有創(chuang)見的(de)學(xue)術(shu)論文(wen)(wen)文(wen)(wen)章、行(xing)業最(zui)新科(ke)研成果,扼要報道(dao)階段性研究成果和重要研究工作的(de)最(zui)新進展,選(xuan)載對學(xue)科(ke)發(fa)展起(qi)指導作用的(de)綜(zong)述與(yu)專論,促進學(xue)術(shu)發(fa)展,為廣大讀者服務。該刊是一本國(guo)際(ji)優秀(xiu)雜志(zhi),在國(guo)際(ji)上有很高的(de)學(xue)術(shu)影響力。

基本信息:
期刊簡(jian)稱:J MED BIOMED SCI
是否OA:未開放
是否預警:
Gold OA文章占比:0.00%
出版信息:
出版語言(yan):English
評價信息:
JCR分區:Q3
影響因子:0.4
雜志(zhi)介紹 JCR分區 CiteScore 投(tou)稿經驗

雜志介紹

Journal Of Medical And Biomedical Science雜志介紹

《Journal Of Medical And Biomedical Science》是一本(ben)以(yi)English為主(zhu)的(de)未開放獲取國際優秀期(qi)刊(kan)(kan),中(zhong)文名稱(cheng)醫學(xue)(xue)與生物醫學(xue)(xue)科學(xue)(xue)雜志,本(ben)刊(kan)(kan)主(zhu)要出版、報道領域的(de)研(yan)究動(dong)態以(yi)及在(zai)該(gai)領域取得的(de)各方面的(de)經(jing)驗(yan)和科研(yan)成果,介紹該(gai)領域有(you)關本(ben)專(zhuan)業(ye)的(de)最新進展(zhan),探討行(xing)業(ye)發(fa)展(zhan)的(de)思(si)路和方法,以(yi)促進學(xue)(xue)術信(xin)息交流,提高行(xing)業(ye)發(fa)展(zhan)。該(gai)刊(kan)(kan)已被國際權威(wei)數據庫SCIE收錄(lu),為該(gai)領域相關學(xue)(xue)科的(de)發(fa)展(zhan)起到了(le)良好的(de)推動(dong)作用(yong),也得到了(le)本(ben)專(zhuan)業(ye)人員的(de)廣(guang)泛認可。該(gai)刊(kan)(kan)最新影響因(yin)子為0.4,

英文介紹

Journal Of Medical And Biomedical Science雜志英文介紹

Journal of Medical and Biomedical Science is a leading academic journal dedicated to publishing innovative research results in the fields of medicine and biomedical sciences. This magazine covers multiple subfields such as basic medicine, clinical medicine, biomedical engineering, and molecular biology, providing readers with a comprehensive knowledge platform. As a highly influential journal, the magazine has attracted submissions from internationally renowned scholars and research teams. The magazine adopts a strict peer review process to ensure that the published articles have high quality and academic value.

It not only focuses on the latest scientific research progress, but also emphasizes the importance of clinical applications and translational medicine. This journal aims to promote cross disciplinary collaboration between the fields of medicine and biomedical sciences, providing scientific evidence for addressing global health issues. By reading this magazine, readers can access the latest academic achievements and industry trends, and learn about cutting-edge research in the fields of medicine and biomedical sciences. Magazines are important reference materials for medical researchers, clinical doctors, and biomedical engineers, as well as a window for the public to understand medical progress.

JCR分區(2023-2024年最新版)

Journal Of Medical And Biomedical Science雜志 JCR分區信息

按JIF指標學(xue)科分(fen)區
學科:MEDICINE, GENERAL & INTERNAL
收錄子集:ESCI
分區:Q3
排名:234 / 325
百分位:

28.2%

按JCI指標學科分區(qu)
學科:MEDICINE, GENERAL & INTERNAL
收錄子集:ESCI
分區:Q3
排名:237 / 329
百分位:

28.12%

JCR分區:JCR分(fen)(fen)區(qu)來自科(ke)睿(rui)唯安公司,JCR是一個獨(du)特的(de)多學科(ke)期(qi)刊(kan)(kan)評價工(gong)具,為唯一提供(gong)基(ji)于(yu)引文數(shu)(shu)據的(de)統計信息的(de)期(qi)刊(kan)(kan)評價資源(yuan)。每年發布的(de)JCR分(fen)(fen)區(qu),設(she)置了254個具體學科(ke)。JCR分(fen)(fen)區(qu)根據每個學科(ke)分(fen)(fen)類按照(zhao)期(qi)刊(kan)(kan)當年的(de)影響因(yin)子高低將(jiang)期(qi)刊(kan)(kan)平均分(fen)(fen)為4個區(qu),分(fen)(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)區(qu)中期(qi)刊(kan)(kan)的(de)數(shu)(shu)量(liang)是均勻分(fen)(fen)為四個部分(fen)(fen)的(de)。

CiteScore 評價數據(2024年(nian)最新版)

Journal Of Medical And Biomedical Science雜志CiteScore 評價數據

歷年影響因子和期刊自引率

投稿經驗

Journal Of Medical And Biomedical Science雜志投稿經驗

該(gai)雜志是一(yi)本國際優秀(xiu)雜志,在(zai)國際上(shang)有(you)較高的學術(shu)影(ying)響力,行業關注度很(hen)高,已被(bei)國際權威(wei)數據庫SCIE收錄,該(gai)雜志在(zai)綜合(he)專業領域專業度認可很(hen)高,對稿件內容(rong)的創(chuang)新性和學術(shu)性要求很(hen)高,作為一(yi)本國際優秀(xiu)雜志,一(yi)般投(tou)稿過(guo)審(shen)(shen)時間(jian)都(dou)較長(chang),投(tou)稿過(guo)審(shen)(shen)時間(jian)平(ping)均 ,如果想投(tou)稿該(gai)刊要做好(hao)時間(jian)安(an)排。版面費不祥。該(gai)雜志近(jin)兩年未被(bei)列入預警(jing)名單,建議(yi)您(nin)投(tou)稿。如您(nin)想了解更多投(tou)稿政策及投(tou)稿方案,請咨(zi)詢客服。

免責聲明

若用戶需(xu)要出版服務(wu),請聯(lian)系出版商。